COMPLEX THERAPHY EFFECT IN AUTOIMMUNE DISEASES
Article Sidebar
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Main Article Content
Аннотация:
This comprehensive observational cohort study meticulously evaluated the effectiveness and safety associated with the combination therapy of adalimumab and methotrexate in individuals diagnosed with the debilitating condition known as rheumatoid arthritis (RA). The participants in this investigation were systematically categorized into three distinct groups, each receiving different treatment regimens. The findings revealed that the synergistic combination of adalimumab and methotrexate demonstrated a statistically significant superiority over methotrexate used as a standalone treatment in achieving clinically meaningful responses, specifically measured by ACR20, ACR50, and ACR70, during a rigorous nine-month treatment period. In this context, Group IB, which was administered a higher dosage of methotrexate, displayed marginally improved rates of clinical improvement compared to Group IA; however, it is worth noting that the difference between these two groups did not reach statistical significance.
Article Details
Как цитировать:
Библиографические ссылки:
Ibragimov, K. I. (2022a). The risk of cardiovascular disease in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: A clinic based case control study. Journal of Global Health Reports, 4(2). http://joghr.com/index.php/JGHR/article/view/32
Ibragimov, K. I. (2022b). The risk of cardiovascular disease in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: A clinic based case control study. Journal of Global Health Reports, 4(2). http://joghr.com/index.php/JGHR/article/view/32
Ibragimov, K., Keane, G., Glaría, C. C., Cheng, J., & Llosa, A. (2019). Haloperidol versus olanzapine for people with schizophrenia. The Cochrane Database of Systematic Reviews, 2019(10), CD013425.
Ibragimov, K., Keane, G. P., Glaría, C. C., Cheng, J., & Llosa, A. E. (2024). Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders. Cochrane Database of Systematic Reviews, 7. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013425.pub2/abstract
Ibragimov, K., Palma, M., Keane, G., Ousley, J., Crowe, M., Carreno, C., Casas, G., Mills, C., & Llosa, A. (2021). Digital mental health care in humanitarian & crisis settings: A mixed-methods exploration during the COVID-19 pandemic. https://europepmc.org/article/ppr/ppr382732
Ibragimov, K., Palma, M., Keane, G., Ousley, J., Crowe, M., Carreño, C., Casas, G., Mills, C., Llosa, A., M. S. F. Mental Health Working Group, Marques, A., Tijerino, A.-M., Droste, A., Echeverri, C., Fredj, N., Sleit, R., & Sultan, S. F. (2022). Shifting to Tele-Mental Health in humanitarian and crisis settings: An evaluation of Médecins Sans Frontières experience during the COVID-19 pandemic. Conflict and Health, 16(1), 6. https://doi.org/10.1186/s13031-022-00437-1
Ibragimov, K., Perles-Ribes, J. F., & Ramón-Rodríguez, A. B. (2022). The impact of climate change on tourism demand: Evidence from Kazakhstan. Anatolia, 33(2), 293–297. https://doi.org/10.1080/13032917.2022.2029510
Ibragimov, K., Sultonov, I., & Ravshanova, M. (2024). The Effectiveness of the Combination Therapy with biologic DMARDS in Rheumatoid Arthritis. Frontiers of Global Science, 2(1), 17–24.
Khasan, I., Ibrat, A., Islomovich, S. I., Sukhrobovna, R. M., Islamova, K., & Shuxrat, Z. (n.d.). The Association Between Cardiovascular Disease and Conventional DMARDs in Patients with Rheumatoid Arthritis. International Journal of Health Sciences, 6(S8), 5053–5059.
Ravshanova, M., Ibragimov, K., Uralov, R., Xasanov, F., Islamova, K., Abdushukurova, K., Sultonov, I., & Axmedov, I. (2024). Clinical and Immunological Characteristics of Patients with Rheumatoid Arthritis on Synthetic DMARDS Therapy. Frontiers of Global Science, 2(1), 41–47.
Ravshanova, M. S., & Ibragimov, K. I. (2022). EFFECTIVENESS OF TRANSVAGINAL ULTRASOUND IN DIAGNOSIS OF ECTOPIC PREGNANCY. INTERNATIONAL SCIENTIFIC CONFERENCE" INNOVATIVE TRENDS IN SCIENCE, PRACTICE AND EDUCATION, 1(2), 114–115. https://scholar.google.com/scholar?cluster=6826578166019760384&hl=en&oi=scholarr
Tashinova, L., Khamraeva, N., Mambetova, L., Khasanov, F., & Ibragimov, K. (2023). Risk factors for the development of systemic lupus erythematosus (sle) in asians: A research case-control. BIO Web of Conferences, 65, 05017. https://www.bio-conferences.org/articles/bioconf/abs/2023/10/bioconf_ebwff2023_05017/bioconf_ebwff2023_05017.html